title: Sirolimus: not so sparing in the Spare-the-Nephron trial.
authors.forename: M Khaled
authors.initials: MK
authors.lastname: Shamseddin
authors.forename: Ankur
authors.initials: A
authors.lastname: Gupta
mesh_terms: D065095:Calcineurin Inhibitors; D003131:Combined Modality Therapy; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006084:Graft Rejection / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D009399:Nephrons / Q000187:drug effects* / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D020123:Sirolimus / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D020123:Sirolimus